AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33116470 — intervention group
Group type: COMPARATOR
Intervention: Non-steroid users
Number of subjects: 1237
Study 35536726 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with 30 pulses per minute
Number of subjects: 90
Study 35536726 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion with 70 pulses per minute
Number of subjects: 90
Study 35536726 — intervention group
Group type: COMPARATOR
Intervention: Non-pulsatile perfusion
Number of subjects: 90
Study 34236951 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic safety education intervention
Number of subjects: 0
Study 34236951 — intervention group
Group type: COMPARATOR
Intervention: Control condition of an occupational therapy driving intervention
Number of subjects: 0
Study 32849284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical containing Bergamot polyphenol fraction and Cynara Cardunculus extract, 300 mg/day for 12 weeks
Number of subjects: 102
Study 32849284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 32849284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical
Number of subjects: 102
Study 35622972 — intervention group
Group type: COMPARATOR
Intervention: Pacritinib (PAC) 400 mg daily in PERSIST-1
Number of subjects: 0
Study 35622972 — intervention group
Group type: COMPARATOR
Intervention: Pacritinib (PAC) 400 mg daily or 200 mg twice daily in PERSIST-2
Number of subjects: 0
Study 35622972 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC) 200 mg twice daily in PAC203 study
Number of subjects: 0
Study 32270865 — intervention group
Group type: EXPERIMENTAL
Intervention: Group electronic monitoring of hand hygiene
Number of subjects: 26
Study 32270865 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurement)
Number of subjects: 26
Study 34979178 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily steps (average 3,460 ± 1,768 steps per day)
Number of subjects: 66
Study 36344987 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral doxycycline
Number of subjects: 13
Study 36344987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 36296964 — intervention group
Group type: EXPERIMENTAL
Intervention: INTAKE24©
Number of subjects: 55
Study 36296964 — intervention group
Group type: COMPARATOR
Intervention: ASA24®
Number of subjects: 55
Study 33377242 — intervention group
Group type: EXPERIMENTAL
Intervention: C677T genotype
Number of subjects: 1023
Study 33377242 — intervention group
Group type: EXPERIMENTAL
Intervention: A1298C genotype
Number of subjects: 1023
Study 33377242 — intervention group
Group type: EXPERIMENTAL
Intervention: Total homocysteine (HCY) levels
Number of subjects: 1023
Study 35353553 — intervention group
Group type: EXPERIMENTAL
Intervention: Actionable alterations detected in tumors
Number of subjects: 1000
Study 35353553 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm assignment
Number of subjects: 1000
Study 35353553 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrollment in treatment arms
Number of subjects: 1000
Study 35353553 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior clinical molecular testing history
Number of subjects: 1000
Study 35353553 — intervention group
Group type: EXPERIMENTAL
Intervention: Actionable alterations in the mitogen-activated protein kinase signaling pathway
Number of subjects: 1000
Study 34310692 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg·kg-1
Number of subjects: 78
Study 34310692 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 2 µg·kg-1
Number of subjects: 78
Study 32169459 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Cycling (AC) group, n=55, 45 min sessions, 2 times per week for 12 weeks
Number of subjects: 111
Study 32169459 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group, n=47
Number of subjects: 111
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory naming-related high gamma augmentation
Number of subjects: 65
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture naming-related high gamma augmentation
Number of subjects: 65
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Naming-related low gamma augmentation and alpha/beta attenuation
Number of subjects: 65
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory naming-based model
Number of subjects: 65
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual resection of an electrical stimulation mapping-defined language site
Number of subjects: 65
Study 35313351 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual resection of an electrical stimulation mapping-defined receptive language site
Number of subjects: 65
Study 34433897 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus pumilus inoculated seeds at 0.25 mg kg‐1 of CdSO4
Number of subjects: 0
Study 34433897 — intervention group
Group type: COMPARATOR
Intervention: Bacillus pumilus uninoculated seeds at 0.75 mg kg‐1 of CdSO4
Number of subjects: 0
Study 34433897 — intervention group
Group type: COMPARATOR
Intervention: Control (uninoculated seeds with no Cd)
Number of subjects: 0
Study 35733400 — intervention group
Group type: EXPERIMENTAL
Intervention: PLUM risk calculator (RC)
Number of subjects: 1010
Study 35733400 — intervention group
Group type: COMPARATOR
Intervention: PBCG risk calculator (RC)
Number of subjects: 1010
Study 35594778 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐CBT‐I (internet-delivered cognitive-behavioral therapy for insomnia)
Number of subjects: 255
Study 35594778 — intervention group
Group type: COMPARATOR
Intervention: Control group (initial control group had access to e‐CBT‐I)
Number of subjects: 255
Study 34766929 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular seed acupressure
Number of subjects: 117
Study 34766929 — intervention group
Group type: COMPARATOR
Intervention: Auricular acupuncture
Number of subjects: 117
Study 34766929 — intervention group
Group type: COMPARATOR
Intervention: Auricular massage
Number of subjects: 117
Study 33040826 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS group
Number of subjects: 60
Study 33040826 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS + pcDNA group
Number of subjects: 60
Study 33040826 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35311633 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes with produce allocations (PAE, n 39)
Number of subjects: 120
Study 35311633 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes only (EO, n 36)
Number of subjects: 120
Study 35311633 — intervention group
Group type: COMPARATOR
Intervention: Control group (n 45)
Number of subjects: 120
Study 33532995 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg·kg−1 bolus before surgery, followed by 0.05 mg·kg−1·hr−1 infusion until end of surgery)
Number of subjects: 100
Study 33532995 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 100
Study 32100388 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising >4 hr before bedtime
Number of subjects: 43
Study 32100388 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising with daylight exposure
Number of subjects: 43
Study 35270624 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT) 500 mg, three caplets
Number of subjects: 11
Study 35270624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA), three gelatin capsules
Number of subjects: 11
Study 35270624 — intervention group
Group type: COMPARATOR
Intervention: Baseline (BSL), nothing ingested
Number of subjects: 11
Study 34945073 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod
Number of subjects: 104
Study 34945073 — intervention group
Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 104
Study 34945073 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod (CIN2p16+ subgroup)
Number of subjects: 104
Study 34945073 — intervention group
Group type: COMPARATOR
Intervention: LLETZ (CIN2p16+ subgroup)
Number of subjects: 104
Study 34686632 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Gait Training (RAGT)
Number of subjects: 37
Study 34686632 — intervention group
Group type: COMPARATOR
Intervention: Conventional Gait Training
Number of subjects: 37
Study 36401407 — intervention group
Group type: EXPERIMENTAL
Intervention: Sopoongsan (treatment group, n = 10)
Number of subjects: 20
Study 36401407 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group, n = 10)
Number of subjects: 20
Study 34102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth services (telephone or videoconference)
Number of subjects: 147
Study 34102012 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147
Study 34102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth services
Number of subjects: 147
Study 34102012 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone services
Number of subjects: 147
Study 32877450 — intervention group
Group type: EXPERIMENTAL
Intervention: Native pop songs (NAT)
Number of subjects: 65
Study 32877450 — intervention group
Group type: EXPERIMENTAL
Intervention: International pop songs (INT)
Number of subjects: 65
Study 32877450 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-specific songs (20 randomly selected)
Number of subjects: 65
Study 32877450 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental design
Number of subjects: 65
Study 32877450 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of relationships between memory types and selected variables
Number of subjects: 65
Study 35467095 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel treatment in mCRPC patients
Number of subjects: 19
Study 35467095 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel treatment in mHSPC patients
Number of subjects: 19
Study 34400961 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (0.14 mg/kg)
Number of subjects: 40
Study 34400961 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched to olanzapine)
Number of subjects: 40
Study 36356214 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxinium modular head with Spectron EF CoCrMo stem
Number of subjects: 150
Study 36356214 — intervention group
Group type: EXPERIMENTAL
Intervention: CoCrMo modular head with Spectron EF CoCrMo stem
Number of subjects: 150
Study 36356214 — intervention group
Group type: COMPARATOR
Intervention: Charnley monoblock stainless steel stem
Number of subjects: 150
Study 33690687 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme gradient boosting
Number of subjects: 16120
Study 33690687 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 16120
Study 32036964 — intervention group
Group type: EXPERIMENTAL
Intervention: CUR (400 mg/kg curcumin)
Number of subjects: 720
Study 32036964 — intervention group
Group type: EXPERIMENTAL
Intervention: OTA + CUR (2 mg/kg OTA plus 400 mg/kg curcumin)
Number of subjects: 720
Study 32036964 — intervention group
Group type: COMPARATOR
Intervention: OTA (2 mg/kg OTA)
Number of subjects: 720
Study 35659763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency turbinate reduction followed by intranasal steroid and Antihistamine H-1 (AH-1)
Number of subjects: 32
Study 35659763 — intervention group
Group type: COMPARATOR
Intervention: Intranasal steroid and Antihistamine H-1 (AH-1)
Number of subjects: 32
Study 33215307 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicruciate-retaining total knee arthroplasty (BCR)
Number of subjects: 48
Study 33215307 — intervention group
Group type: COMPARATOR
Intervention: Cruciate-retaining total knee arthroplasty (CR)
Number of subjects: 48
Study 36254038 — intervention group
Group type: EXPERIMENTAL
Intervention: CTR with ultrasound guidance (CTR‐US)
Number of subjects: 120
Study 36254038 — intervention group
Group type: COMPARATOR
Intervention: mini‐open CTR (mOCTR)
Number of subjects: 120
Study 34217906 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-hydroxyvitamin D3 (25OHD3)
Number of subjects: 72
Study 34217906 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial diet
Number of subjects: 72
Study 34217906 — intervention group
Group type: COMPARATOR
Intervention: Diluent (control)
Number of subjects: 72
Study 34217906 — intervention group
Group type: EXPERIMENTAL
Intervention: D3
Number of subjects: 72
Study 34217906 — intervention group
Group type: COMPARATOR
Intervention: ReCaP diet
Number of subjects: 72
Study 32769261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on multivariable regression analysis including 5 risk factors.
Number of subjects: 121
Study 32769261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram score for predicting multidrug-resistant bacterial infection risk.
Number of subjects: 121
Study 35241426 — intervention group
Group type: EXPERIMENTAL
Intervention: deucravacitinib 6 mg once a day
Number of subjects: 203
Study 35241426 — intervention group
Group type: EXPERIMENTAL
Intervention: deucravacitinib 12 mg once a day
Number of subjects: 203
Study 35241426 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 203
Study 33051119 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting category of surgery
Number of subjects: 20000
Study 33051119 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting laterality of surgery
Number of subjects: 20000
Study 33051119 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting constraint type
Number of subjects: 20000
Study 33051119 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting presence of patellar resurfacing
Number of subjects: 20000
Study 33051119 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithms for detecting implant model
Number of subjects: 20000
Study 36709485 — intervention group
Group type: EXPERIMENTAL
Intervention: Provisional strategy
Number of subjects: 438
Study 36709485 — intervention group
Group type: EXPERIMENTAL
Intervention: All strategies
Number of subjects: 438
Study 33879820 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE), 40 min, cycle ergometer, 60% HRR
Number of subjects: 33
Study 33879820 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE), 40 min, 4×12 lower limb repetitions, 60% 1-RM
Number of subjects: 33
Study 33879820 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Exercise (CE), 20-min RE + 20-min AE
Number of subjects: 33
Study 35427456 — intervention group
Group type: EXPERIMENTAL
Intervention: Koru Mindfulness intervention
Number of subjects: 111
Study 35427456 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 111
Study 33750285 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 193
Study 33750285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 32811464 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance Group (DG) - Brazilian dance program inspired by Samba and Forró rhythms, 24 sessions of 1 hour each, twice per week for 12 weeks.
Number of subjects: 18
Study 32811464 — intervention group
Group type: COMPARATOR
Intervention: Walking Group (WG) - Walking program, same duration and frequency as DG.
Number of subjects: 18
Study 35763398 — intervention group
Group type: EXPERIMENTAL
Intervention: Socket shield technique with immediate implant placement in contact (Group A)
Number of subjects: 46
Study 35763398 — intervention group
Group type: COMPARATOR
Intervention: Socket shield technique with immediate implant placement leaving a gap (Group B)
Number of subjects: 46
Study 35763398 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study 34511058 — intervention group
Group type: EXPERIMENTAL
Intervention: EKIT tool (digital medical decision aid)
Number of subjects: 1080
Study 34511058 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 1080
Study 36332653 — intervention group
Group type: COMPARATOR
Intervention: Combination prevention intervention with universal antiretroviral therapy (ART; arm A)
Number of subjects: 20422
Study 36332653 — intervention group
Group type: COMPARATOR
Intervention: Prevention intervention with ART provided according to local guidelines (arm B)
Number of subjects: 20422
Study 36332653 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care (arm C)
Number of subjects: 20422
Study 34921201 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided self-regulation learning (CA-SRL)
Number of subjects: 72
Study 34921201 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional learning (TL)
Number of subjects: 72
Study 34921201 — intervention group
Group type: COMPARATOR
Intervention: Demonstration learning (DL)
Number of subjects: 72
Study 32597621 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling suit recovery group
Number of subjects: 11
Study 36438688 — intervention group
Group type: EXPERIMENTAL
Intervention: Camrelizumab (SHR‐1210) combined with gemcitabine plus cisplatin (GP) chemotherapy
Number of subjects: 60
Study 36438688 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin (GP) chemotherapy
Number of subjects: 60
Study 33248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (HbA1c target <6.0%)
Number of subjects: 9746
Study 33248240 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic control (HbA1c target 7.0-7.9%)
Number of subjects: 9746
Study 33248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal 10 gm filament test
Number of subjects: 9746
Study 33248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of ulceration
Number of subjects: 9746
Study 33248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal appearance on foot examination
Number of subjects: 9746
Study 33248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean postrandomization HbA1c
Number of subjects: 9746
Study 33064609 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% isoflurane
Number of subjects: 12
Study 33064609 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 12
Study 33064609 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% desflurane
Number of subjects: 12
Study 33064609 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane and sevoflurane
Number of subjects: 12
Study 33064609 — intervention group
Group type: EXPERIMENTAL
Intervention: desflurane
Number of subjects: 12
Study 36212931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (2 mg/kg bolus over 5 minutes, then 1.5 mg/kg/h infusion)
Number of subjects: 83
Study 36212931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg over 5 minutes, followed by saline)
Number of subjects: 83
Study 36212931 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% saline)
Number of subjects: 83
Study 36212931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine and Dexamethasone (compared to saline)
Number of subjects: 83
Study 34103017 — intervention group
Group type: EXPERIMENTAL
Intervention: PREDICT intervention
Number of subjects: 14
Study 34103017 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 35999678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (1 μg/kg) combined with oral midazolam (0.7 mg/kg)
Number of subjects: 32
Study 35999678 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (0.7 mg/kg) alone
Number of subjects: 32
Study 34380301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD), physical exercises in the gym, daily walking up to 3-5 km/day
Number of subjects: 120
Study 34380301 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet (LCD), physical exercises in the gym, daily walking up to 3-5 km/day, nutraceutical correction
Number of subjects: 120
Study 35749413 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week Tai Chi program (45 minutes per session, twice a week)
Number of subjects: 40
Study 35749413 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 40
Study 33414036 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 69
Study 33414036 — intervention group
Group type: COMPARATOR
Intervention: In-person
Number of subjects: 69
Study 32255212 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made 3D-printed drill guides
Number of subjects: 19
Study 32255212 — intervention group
Group type: COMPARATOR
Intervention: Freehand insertion (control group)
Number of subjects: 19
Study 34873674 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2256294 (10 mg once daily for 10 days)
Number of subjects: 19
Study 34873674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 34873674 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2256294
Number of subjects: 19
Study 33677694 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training Group (STG)
Number of subjects: 38
Study 33677694 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Strength Training Group (FTG)
Number of subjects: 38
Study 33677694 — intervention group
Group type: COMPARATOR
Intervention: Young Group (Y)
Number of subjects: 38
Study 32106075 — intervention group
Group type: EXPERIMENTAL
Intervention: External Counterpulsation (ECP)
Number of subjects: 13
Study 34985184 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling exercise (6 minutes)
Number of subjects: 16
Study 34985184 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant power output exercise bouts to task failure (TTF) at varying intensities (15% below MLSS, 10 W below MLSS, MLSS, 10 W above MLSS)
Number of subjects: 16
Study 33779520 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Aware (web-based SHE program)
Number of subjects: 331
Study 35830070 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycorrhizal inoculants associated with Bradyrhizobium BR3267 strain
Number of subjects: 5
Study 35830070 — intervention group
Group type: EXPERIMENTAL
Intervention: Acaulospora longula treatments
Number of subjects: 5
Study 35830070 — intervention group
Group type: EXPERIMENTAL
Intervention: G. albida + Bradyrhizobium BR 3267
Number of subjects: 5
Study 35830070 — intervention group
Group type: EXPERIMENTAL
Intervention: A. longula
Number of subjects: 5
Study 35830070 — intervention group
Group type: COMPARATOR
Intervention: Control (reference)
Number of subjects: 5
Study 33528904 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg/day) with no meal announcement
Number of subjects: 30